IDO2 and neoplasm: Anti-cancer activity in vivo has been demonstrated through the restriction of tumor growth within lung carcinoma cells of C57BL/6 mice that overexpressed indoleamine 2,3-dioxygenase (IDO), a tryptophan-catalyzing enzyme that allows tumor cells to evade host immune activity [516].